MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: *Investment Round
Venture Capital: Series A
Coferon
Parents
*Architects: Drug Delivery (Oral & Smart Pills)
*Industry: New York
Venture Capital: Series A
Children
Amount: $7.1M Round: Series A Investor(s) Argent Ventures
Coferon is developing orally active drugs that reach currently "undruggable" targets.
Industry: Drug Development Sub-Industry: N/A
Their platform consists of molecules that have the ability to permeate cell membranes and then once inside, assemble to become larger molecules.